Compare BLCO & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | WH |
|---|---|---|
| Founded | 1853 | 2017 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.7B |
| IPO Year | N/A | N/A |
| Metric | BLCO | WH |
|---|---|---|
| Price | $17.74 | $80.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $17.25 | ★ $92.92 |
| AVG Volume (30 Days) | 364.8K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.08 | $5.13 |
| Revenue Next Year | $5.85 | $5.56 |
| P/E Ratio | ★ N/A | $18.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.45 | $69.21 |
| 52 Week High | $17.91 | $113.07 |
| Indicator | BLCO | WH |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 59.19 |
| Support Level | $16.60 | $77.07 |
| Resistance Level | $17.45 | $82.00 |
| Average True Range (ATR) | 0.51 | 2.68 |
| MACD | 0.07 | 0.48 |
| Stochastic Oscillator | 92.22 | 83.22 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
As of June 30, 2025, Wyndham Hotels & Resorts operates 846,700 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands, as of the end of 2024. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms, as of the end of 2024.